CD274 and head and neck squamous cell carcinoma: In addition, PD-L1 signalling can be regulated by several pathways, such as PI3K, Akt/PKB, and MAPK; these are frequently altered in HNSCC patients, leading to PD-L1 being subjected to extreme temporal variation and spatial heterogeneity [45,46,47].